The ALS Association

Ice Bucket Challenge Progress
Brian Frederick
The ALS Association
(202) 464-8612



Prize4Life Merges with The ALS Association

Founder Avi Kremer Joins The ALS Association Team

Washington, D.C. (November 1, 2018) — Prize4Life has dissolved its organization and transferred all of its assets and resources to The ALS Association, the Association announced Thursday. Prize4Life founder Avi Kremer has joined the Association as a consultant.

“We see The ALS Association as a leader that can unite and coordinate the fragmented ALS landscape and maximize efficiencies,” Kremer said. “As an ALS patient, I believe The ALS Association is the best organization to move us forward to a cure.”

Prize4Life was a nonprofit organization whose mission was to accelerate the discovery of treatments and a cure for ALS by using powerful incentives to attract new people and drive innovation.

“After 12 years of promoting ALS research, I realized that the fragmentation in the ALS landscape hinders the quest to find a cure, because when different patient organizations compete, efficiencies aren’t optimized,” said Kremer.

Kremer was diagnosed with ALS in 2004, while a student at Harvard Business School. In 2006, he co-founded Prize4Life and served as its CEO for 10 years. Before his ALS diagnosis, he was a project manager at Elbit Systems, and a captain in the Israeli army. He was the 2007 recipient of the Laurence A. Rand Prize from The ALS Association, and received the Israeli Prime Minister Award for Innovation and Entrepreneurship in 2011.

Prize4Life and The ALS Association have been longtime collaborators, partnering most recently in 2016 with the ALS Assistive Technology Challenge. The Challenge offered a $400,000 prize for the development of flexible, accessible technology to help people with ALS communicate with ease, and was open to academics, industry, young start-ups, and anyone who believed he could make a difference for people living with ALS.

“Prize4Life created a new way for funding ALS research and empowering researchers, which has undoubtedly advanced the research,” said Calaneet Balas, president and CEO of The ALS Association. “We’re deeply honored to carry on the important work started by Prize4Life and very excited to work with Avi to continue raising funds to help us get closer to effective treatments and a cure.”

About ALS
ALS (amyotrophic lateral sclerosis) is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which often leads to total paralysis and death within two to five years of diagnosis. For unknown reasons, veterans are twice as likely to develop ALS as the general population.

About The ALS Association
The ALS Association is the only national nonprofit organization fighting ALS on every front. By leading the way in global research, providing assistance for people with ALS through a nationwide network of chapters, coordinating multidisciplinary care through certified clinical care centers, and fostering government partnerships, The Association builds hope and enhances quality of life while aggressively searching for new treatments and a cure. For more information about The ALS Association, visit our website at

About Prize4Life
Prize4Life was a 501(c)(3) nonprofit organization whose mission was to accelerate the discovery of treatments and a cure for ALS by using powerful incentives to attract new people and drive innovation. Prize4Life believed that solutions to some of the biggest challenges in ALS research would require out-of-the-box thinking, and that some of the most critical discoveries may come from unlikely places.

Powered by Blackbaud
nonprofit software